logo
Select company
Select metric
Ticker Information

Ticker

CCCC

Company Name

C4 THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

C4 THERAPEUTICS INC - Interest Coverage Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CCCC - Int. Coverage Historical data
DateEarning Before Interest & Taxes (EBIT)Interest ExpenseInterest Coverage
6/30/2025$ -111.45M$ 00
3/31/2025$ -103.15M$ 00
12/31/2024$ -105.19M$ 00
9/30/2024$ -105.22M$ 00
6/30/2024$ -106.42M$ 167K-637.25
3/31/2024$ -124.03M$ 767K-161.7
12/31/2023$ -129.84M$ 1.37M-94.57
9/30/2023$ -131.95M$ 1.97M-66.84
6/30/2023$ -137.48M$ 2.36M-58.23
3/31/2023$ -129.04M$ 2.29M-56.23
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • C4 THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Coverage stands at -53.48.
  • Over the past 5 years, C4 THERAPEUTICS INC's average Int. Coverage has been -101.97.
  • The median Int. Coverage for C4 THERAPEUTICS INC during this period was -54.86
  • C4 THERAPEUTICS INC reached its highest Int. Coverage over the past 5 years at -32.83.
  • The lowest Int. Coverage recorded by C4 THERAPEUTICS INC in the same timeframe -637.25

C4 THERAPEUTICS INC's Int. Coverage vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Coverage Benchmarks
CompanyInt. Coverage
VYGR : VOYAGER THERAPEUTICS INC -EDIT : EDITAS MEDICINE INC -FENC : FENNEC PHARMACEUTICALS INC -2.67OABI : OMNIAB INC -MGX : METAGENOMI INC -TLSI : TRISALUS LIFE SCIENCES INC -5.44SPRO : SPERO THERAPEUTICS INC -CELU : CELULARITY INC -8.27UTMD : UTAH MEDICAL PRODUCTS INC -IVVD : INVIVYD INC -

Definition of Interest Coverage

[Calculation] The Interest Coverage Ratio is a debt and profitability ratio that describes how easily a business can pay interest on its outstanding [Debt]. It is calculated by dividing the company’s earnings before interest and taxes [EBIT] by its interest expenses [IntExp].
EBIT / Int. Exp.
(=) Int. Coverage
Int. Coverage for C4 THERAPEUTICS INC is calculated as follows: EBIT [ $ -65.73M ] / Int. Exp. [ $ 1.23M ]
(=) Int. Coverage [ -53.48 ]

CCCC - Interest Coverage, Last 5 years

-637.25

Minimum

Jun 30, 2024

-32.83

Maximum

Sep 30, 2021

-101.97

Average

-54.86

Median

Int. Coverage Benchmark Analysis

The chart above depicts the distribution of Int. Coverage for companies in the Total Stock Market. The average Int. Coverage of the companies is 2.16 with a standard deviation of 8.45.
The following table provides additional summary stats:
Int. Coverage in the Market:
filtered constituents2.37K
min-25.49
max28.75
average2.16
median2.09
std8.45